BridgeBio Pharma: Number of Employees 2018-2026 | BBIO
Interactive chart of BridgeBio Pharma (BBIO) annual worldwide employee count from 2018 to 2026.
- BridgeBio Pharma total number of employees in 2025 was 839, a 14.93% increase from 2024.
- BridgeBio Pharma total number of employees in 2024 was 730, a 32.73% increase from 2023.
- BridgeBio Pharma total number of employees in 2023 was 550, a 40.31% increase from 2022.
- BridgeBio Pharma total number of employees in 2022 was 392, a 32.18% decline from 2021.
| BridgeBio Pharma Annual Employee Count | |
|---|---|
| 2025 | 839 |
| 2024 | 730 |
| 2023 | 550 |
| 2022 | 392 |
| 2021 | 578 |
| 2020 | 385 |
| 2019 | 248 |
| 2018 | 152 |
| 2017 | N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $14.460B | $0.502B |
| BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio Pharma Inc. is based in PALO ALTO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |